Literature DB >> 5069241

Cryoimmunotherapy.

R J Ablin.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5069241      PMCID： PMC1785999          DOI： 10.1136/bmj.3.5824.476

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Serum proteins in patients with benign and malignant diseases of the prostate.

Authors:  R J Ablin; W A Soanes; P M Bronson; M J Gonder
Journal:  Neoplasma       Date:  1971       Impact factor: 2.575

2.  Comparison of tumor immunity after complete excision, cryonecrosis, and in the presence of persistent tumor.

Authors:  H B Neel; A S Ketcham; W G Hammond
Journal:  Surg Forum       Date:  1970

3.  Tumor autoimmunity against methylcholanthrene-induced sarcomas of the rat.

Authors:  K Takeda; M Aizawa; Y Kikuchi; S Yamawaki; K Nakamura
Journal:  Gan       Date:  1966-06
  3 in total
  6 in total

Review 1.  Cryoimmunology for malignant bone and soft-tissue tumors.

Authors:  Hideji Nishida; Norio Yamamoto; Yoshikazu Tanzawa; Hiroyuki Tsuchiya
Journal:  Int J Clin Oncol       Date:  2011-03-12       Impact factor: 3.402

2.  Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation.

Authors:  Moshe Yair Levy; Abhinav Sidana; Wasim H Chowdhury; Steven B Solomon; Charles G Drake; Ronald Rodriguez; Ephraim J Fuchs
Journal:  J Pharmacol Exp Ther       Date:  2009-04-30       Impact factor: 4.030

Review 3.  Adjuvant approaches to enhance cryosurgery.

Authors:  Raghav Goel; Kyle Anderson; Joel Slaton; Franz Schmidlin; Greg Vercellotti; John Belcher; John C Bischof
Journal:  J Biomech Eng       Date:  2009-07       Impact factor: 2.097

4.  Successful treatment of cutaneous metastatic breast cancer with topical treatments that potentially synergize with systemic therapy: A case series.

Authors:  Shalini R Krishnasamy; Timothy H Almazan; Giselle A Suero-Abreu; Jae Y Jung
Journal:  JAAD Case Rep       Date:  2018-08-15

5.  Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity.

Authors:  Ying Wu; Fei Cao; Danyang Zhou; Shuanggang Chen; Han Qi; Tao Huang; Hongtong Tan; Lujun Shen; Weijun Fan
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

Review 6.  Cytoreductive treatment strategies for de novo metastatic prostate cancer.

Authors:  Martin J Connor; Taimur T Shah; Gail Horan; Charlotte L Bevan; Mathias Winkler; Hashim U Ahmed
Journal:  Nat Rev Clin Oncol       Date:  2019-11-11       Impact factor: 66.675
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.